1
0
0
(1 - 13 von 13
)
Inhalation of a Dry Powder …floxacin Formulation in Healthy...
www.scienceopen.com
Authors: Heino Stass, Johannes Nagelschmitz, Stefan Willmann, Heinz Delesen, Abhishek Gupta, Sybille Baumann. Publication date (Electronic): 20 April
…floxacin Dry Powder for Inhalation in Patients with Non-Cystic...
www.proquest.com
Heino Stass, PhD,1 Johannes Nagelschmitz, PhD, MD,1 Dominik Kappeler, MD,2. Knut Sommerer, Dipl Ing,2 Claudius Kietzig, Dipl Ing,2 and Boris Weimann, PhD3. Abstract. Background: …floxacin dry powder for inhalation (…floxacin DPI) is in development as long-term intermittent therapy to reduce the frequency ...
Inhalation of a Dry Powder …floxacin Springer LINKlink.springer.com › article
link.springer.com
· Johannes Nagelschmitz,; Stefan Willmann,; Heinz Delesen,; […] Abhishek Gupta &; Sybille Baumann; -Show ...
Inhalation of a Dry Powder …floxacin Formulation in Healthy...
link.springer.com
Oral and intravenous formulations of …floxacin have established efficacy and safety profiles in respiratory infections. A dry powder for inhalation (DP
…floxacin Dry Powder for Inhalation in Patients with ...Mary Ann Liebert, Inc.
www.liebertpub.com
von H Stass · · Zitiert von: 28 — Heino Stass, PhD,1 Johannes Nagelschmitz, PhD, MD,1 Dominik Kappeler, MD,2. Knut Sommerer, Dipl Ing,2 Claudius Kietzig, Dipl Ing,2 and Boris Weimann, PhD3. von H Stass · · Zitiert von: 28 — Heino Stass, PhD,1 Johannes Nagelschmitz, PhD, MD,1 Dominik Kappeler, MD,2. Knut Sommerer, Dipl Ing,2 Claudius Kietzig, Dipl Ing,2 and Boris Weimann, PhD3.
…floxacin Dry Powder for Inhalation: Inspiratory Flow in ...Mary Ann Liebert, Inc.
www.liebertpub.com
von H Stass · · Zitiert von: 5 — Heino Stass, PhD,1 Johannes Nagelschmitz, PhD,1 Dominik Kappeler, MD,2 Knut Sommerer, Dipl Ing,2. Astrid Patzlaff, PhD,2 and Boris Weimann, PhD3. Abstract. von H Stass · · Zitiert von: 5 — Heino Stass, PhD,1 Johannes Nagelschmitz, PhD,1 Dominik Kappeler, MD,2 Knut Sommerer, Dipl Ing,2. Astrid Patzlaff, PhD,2 and Boris Weimann, PhD3. Abstract.
Inhalation of a dry powder …floxacin formulation in ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von H Stass · · Zitiert von: 105 — Johannes Nagelschmitz, Stefan Willmann, Heinz Delesen, Abhishek Gupta, Sybille Baumann. Affiliation. 1 Bayer Pharma AG, Clinical Pharmacology, Bldg 470, Room ... von H Stass · · Zitiert von: 105 — Johannes Nagelschmitz, Stefan Willmann, Heinz Delesen, Abhishek Gupta, Sybille Baumann. Affiliation. 1 Bayer Pharma AG, Clinical Pharmacology, Bldg 470, Room ...
…floxacin Dry Powder for Inhalation inProQuest
Johannes Nagelschmitz. 1 Bayer Pharma AG, Clinical Pharmacology, Wuppertal, Germany. Dominik Kappeler. 2 Inamed GmbH, Gauting, Germany. Knut Sommerer
…floxacin Dry Powder for Inhalation: Inspiratory Flow in ...Mary Ann Liebert
www.liebertpub.com
von H Stass · · Zitiert von: 5 — Heino Stass, · Johannes Nagelschmitz, · Dominik Kappeler, · Knut Sommerer, · Astrid Patzlaff, and · Boris Weimann.
Inhalation of a Dry Powder …floxacin Formulation in Healthy...
cyberleninka.org
Heino Stass • Johannes Nagelschmitz • Stefan Willmann • Heinz Delesen • Abhishek Gupta • Sybille Baumann. Published online: 20 April
Inhalation of a Dry Powder …floxacin Formulation in ...infona.pl
www.infona.pl
Johannes Nagelschmitz. Clinical Pharmacology, Bayer Pharma AG, Wuppertal, Germany. Stefan Willmann. Bayer Technology Services GmbH ...
Safety and pharmacokinetics of …floxacin dry powder ...Sigma-Aldrich
www.sigmaaldrich.com
— by Heino Stass, Heinz Delesen, Johannes Nagelschmitz, Doris Staab. Journal of aerosol medicine and pulmonary drug delivery. Read more ...
Alle Infos zum Namen "Johannes Nagelschmitz"
Verwandte Suchanfragen zu Johannes Nagelschmitz
Heinz Delesen Sybille Baumann Stefan Willmann | Anne Kirsten Stephan Schwers Astrid Patzlaff | Manuel Endenich Henrik Watz Peter Sandner |
Personen Vorname "Johannes" (37739) Name "Nagelschmitz" (50) |
sortiert nach Relevanz / Datum